LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
Generic: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE
LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE is FDA application ANDA218015, sponsored by GRANULES. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
cGMP Deviations: recall due to not meeting the N-Nitroso Bisoprolol impurity specification limits.
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam
CGMP Deviations: finished products manufactured using active pharmaceutical ingredients whose interm
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of eze
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylam
CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.
Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle
Presence of Foreign Tablets/Capsules: Product complaint received of one Fenofibrate tablet 145mg obs